Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow

Langerhorst, P. et al. (2021). Clin Chem.

PMID: 34643690

NWO logoThis research was (partially) funded by NWO, project 184.034.019